Abstract
Background: Data regarding repeat transvenous lead extraction (TLE) are scarce. The aim of study was to explore the frequency of repeat TLE, its safety, predisposing factors, as well as effectiveness of repeat procedures. Methods: Retrospective analysis of a large single-center database of 3654 TLEs. Results: Repeat TLE was a rare occurrence (193, i.e., 5,28% among 3654 TLEs). Subsequent re-extractions occurred in 12.21% of the patients. Lead failure was the most common cause of re-extraction (51.16%). Cox regression analysis showed that patients who were older at first implantation [HR = 0.987; p = 0.003], had infection-related TLE [HR = 0.392; p < 0.001] and complete procedural success [HR = 0.544; p = 0.034] were less likely to undergo repeat TLE. Functional leads left in place for continuous use [HR = 1.405; p = 0.012] or superfluous leads left in place (abandoned) [HR = 2.370; p = 0.011] were associated with an increased risk of undergoing a repeat procedure. Overall mortality in patients with repeat TLE and subsequent re-extraction in the entire FU period was similar to that in patients without a history of re-extraction [HR = 0.949; p = 0.480]. Conclusions: Repeat TLE was a rare occurrence (5.28%) among TLEs. Left of both active and nonactive leads during TLE increased the risk of re-extraction. Re-extraction has no effect on the long-term mortality.
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference30 articles.
1. Management of cardiac implantable electronic device infections: The challenges of understanding the scope of the problem and its associated mortality;Expert Rev. Cardiovasc. Ther.,2013
2. Knowledge gaps, lack of confidence, and system barriers to guideline implementation among European physicians managing patients with CIED lead or infection complications: A European Heart Rhythm Association/European Society of Cardiology educational needs assessment survey;EP Eur.,2020
3. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: This document was endorsed by the American Heart Association (AHA);Heart Rhythm.,2009
4. Pathways for training and accreditation for transvenous lead extraction: A European Heart Rhythm Association position paper;Europace,2012
5. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction;Heart Rhythm.,2017